Walgreen's Same-Store Sales Dive

Before you go, we thought you'd like these...
Before you go close icon

pillsDrug store giant Walgreen Co. (NYSE: WAG) announced this morning that November same-store sales fell 6.2% year-over-year, primarily due to the impact of generic drug sales replacing sales of higher-priced brand-name drugs. Total sales fell 3.9% from $6.09 billion last year to $5.85 billion.

Pharmacy sales in November fell 4.7%, and same-store pharmacy sales fell 8.8%. Pharmacy sales accounted for 63.2% of monthly sales.

Walgreen did not specifically indicate any impact from its now-resolved dispute with Express Scripts Inc. (NASDAQ: ESRX). During the nine-month fight with Express Scripts, Walgreen's lost millions of customers, and as much as 60% of the total could be gone permanently to competitor CVS Caremark Corp. (NYSE: CVS). Walgreen did say that prescriptions filled at comparable stores fell by 2.9% in November following a 1.8% drop in October.

Walgreen stock is up 2.45% this morning, at $35.12 in a 52-week range of $28.53 to $37.35, even though virtually every metric reported today was down. Even the number of flu shots administered is lower this year.

Paul Ausick

Filed under: 24/7 Wall St. Wire, Retail, Services Tagged: CVS, ESRX, WAG
Read Full Story


S&P 500 2,203.95 -0.76 -0.03%
DJIA 19,201.87 -14.37 -0.07%
NASDAQ 5,309.10 0.20 0.00%
DAX 10,728.44 43.61 0.41%
HANG SENG 22,675.15 169.60 0.75%
NIKKEI 225 18,360.54 85.55 0.47%
USD (per EUR) 1.07 0.00 -0.18%
USD (per CHF) 1.01 0.00 0.27%
JPY (per USD) 113.97 0.11 0.10%
GBP (per USD) 1.27 0.00 0.05%

From Our Partners